Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction: a Phase II Study

NCT06161818 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06161818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06161818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction: a Phase II Study
Lead sponsor
Erasmus Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
September 12, 2025
Completion date
December 1, 2029
Enrollment
216 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the esophagus, esophageal cancer